Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,453 active trials24 approved drugs58 evidence items
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07592910 | A Study of Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have Previously Received Androgen Receptor Pathway Inhibitor Therapy(MOMENT) | not yet recruiting | Phase 2 | 60 | Prostate Cancer Clinical Trials ConsortiumOTHER | 0 | May 18, 2026 | clinicaltrials |
| NCT07564102 | dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy | not yet recruiting | Phase 1 / Phase 2 | 30 | Mochida Medical USA, Inc.INDUSTRY |
| 1 |
| May 15, 2026 |
| clinicaltrials |
| NCT07591467 | Carboplatin-Enhanced Therapy in BRCA-Mutated or Neuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate Cancer(CaBRA) | not yet recruiting | Phase 3 | 330 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT07580651 | Quality and Safety of Real-Time Brachytherapy Treatments: Clinical Implementation of a Multipoint Scintillation Detector for Treatment Monitoring((CurieInVivo)) | not yet recruiting | N/A | 20 | CISSS de Chaudière-AppalachesOTHER_GOV | 0 | May 12, 2026 | clinicaltrials |
| NCT07577895 | Pain Comparison: Transrectal vs. Transperineal Prostate Biopsy(TRAP-PAIN) | not yet recruiting | — | 200 | Kayseri Education and Research HospitalOTHER_GOV | 1 | May 11, 2026 | clinicaltrials |
| NCT07568756 | Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer Evaluation | not yet recruiting | Phase 2 | 60 | University of California, IrvineOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT07568236 | A Trial on Fezolinetant for Vasomotor Symptoms in Men Receiving Androgen Deprivation Therapy (ADT) | not yet recruiting | Phase 2 | 54 | Chinese University of Hong KongOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT07560215 | PROMET-BR - Molecular Profiling of Metastatic Prostate Cancer: a Brazilian Cohort(PROMET-BR) | not yet recruiting | — | 100 | AstraZenecaINDUSTRY | 1 | May 1, 2026 | clinicaltrials |
| NCT07040501 | Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI | not yet recruiting | N/A | 50 | Case Comprehensive Cancer CenterOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT07555600 | Enumeration and Functional Analysis of Circulating Tumor Cells for Homologous Recombination: a Prospective Single-center Study on Advanced/Metastatic Solid Tumors(E-FACTOR) | not yet recruiting | N/A | 300 | Centre Leon BerardOTHER | 0 | Apr 29, 2026 | clinicaltrials |
| NCT07555756 | An International Multicenter Clinical Study on Application of UroMed AI Doctor Based on Large Language Models | not yet recruiting | N/A | 1,080 | First Affiliated Hospital of Guangxi Medical UniversityOTHER | 2 | Apr 29, 2026 | clinicaltrials |
| NCT07264088 | Identifying the Best Follow up Approach for People Who Have Had Treatment to Cure Newly Diagnosed Prostate Cancer(FOLLOW-UP) | not yet recruiting | — | 100,000 | Imperial College LondonOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT07475533 | Low-flow Versus Minimal-flow Sevoflurane Anesthesia During Robot-assisted Laparoscopic Radical Prostatectomy | not yet recruiting | N/A | 70 | Ankara City Hospital BilkentOTHER | 0 | Apr 15, 2026 | clinicaltrials |
| NCT07529418 | The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prostate Cancer PROMS Study(BALANCE) | not yet recruiting | — | 800 | Institute of Cancer Research, United KingdomOTHER | 0 | Apr 14, 2026 | clinicaltrials |
| NCT07526675 | Concomitant Trans-Perineal Prostate Biopsy and Ablation (Bioblation) for Prostate Cancer(Bioblation) | not yet recruiting | N/A | 30 | Benha UniversityOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT07516704 | Safety and Efficacy of Docetaxel, Darolutamide, and Homoharringtonine Combined With Androgen Deprivation Therapy in Neoadjuvant Treatment of High-Risk Prostate Cancer: A Multicenter Prospective, Single-Arm Clinical Study | not yet recruiting | Early Phase 1 | 94 | Zhongda HospitalOTHER | 0 | Apr 8, 2026 | clinicaltrials |
| NCT07516808 | PRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear Microscopy | not yet recruiting | N/A | 20 | Beth Israel Deaconess Medical CenterOTHER | 1 | Apr 8, 2026 | clinicaltrials |
| NCT07492381 | A Prospective, Single-Arm, Pilot Study of the ALPFA BPH PFA System in Men With Low, Intermediate and High-Risk Prostate Cancer | not yet recruiting | N/A | 50 | ALPFA MedicalINDUSTRY | 0 | Apr 7, 2026 | clinicaltrials |
| NCT07516210 | Adaptive Radiotherapy for Safe Hypofractionation(ART-Hypo) | not yet recruiting | Phase 2 | 264 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Apr 7, 2026 | clinicaltrials |
| NCT07290998 | Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Recurrent Prostate Cancer | not yet recruiting | N/A | 12 | Alpha Tau Medical LTD.INDUSTRY | 0 | Apr 6, 2026 | clinicaltrials |
| NCT07484269 | PULSE Registry: for Patients Receiving Lutetium (177Lu) Vipivotide Tetraxetan(PULSE) | not yet recruiting | — | 753 | Novartis PharmaceuticalsINDUSTRY | 0 | Mar 20, 2026 | clinicaltrials |
| NCT07485881 | 18F-PSMA PET/CT Versus CT Alone in Assessment of Prostatic Cancer Patients | not yet recruiting | — | 59 | Assiut UniversityOTHER | 0 | Mar 20, 2026 | clinicaltrials |
| NCT07145437 | Prostate Stereotactic Radiation and Radio-induced Lymphocyte Apoptosis for Predicting Late Toxicities in Prostate Cancer (PROSTERA)(PROSTERA) | not yet recruiting | N/A | 220 | Clinique Sainte ClotildeOTHER | 0 | Mar 18, 2026 | clinicaltrials |
| NCT07480044 | A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly Patients After Urological Surgery | not yet recruiting | N/A | 220 | Zhejiang UniversityOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT07476677 | Darolutamide ± ADT as Neoadjuvant Therapy in High-Risk/Very High-Risk Localized Prostate Cancer(ANDARP) | not yet recruiting | Phase 2 | 60 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Mar 17, 2026 | clinicaltrials |
| NCT07468838 | Feasibility Study of Urinary cfDNA Analysis as a Non-invasive Monitoring Tool in Patients With Prostate or Bladder Cancer(UroDNA) | not yet recruiting | — | 25 | Institut Cancerologie de l'OuestOTHER | 0 | Mar 16, 2026 | clinicaltrials |
| NCT07457164 | A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer | not yet recruiting | Phase 2 | 40 | Antev Ltd.INDUSTRY | 0 | Mar 12, 2026 | clinicaltrials |
| NCT07468396 | A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer | not yet recruiting | Phase 1 | 65 | Gan & Lee Pharmaceuticals.INDUSTRY | 1 | Mar 12, 2026 | clinicaltrials |
| NCT07460726 | PRIAPUS-PCa Study: Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) Impact on Sexual Function on Men With Unfavorable Intermediate Risk Prostate Cancer(PRIAPUS-PCa) | not yet recruiting | — | 130 | CancerCare ManitobaOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT07437482 | Cancer Literacy Education and Awareness Resources for Prostate Care(CLEAR-PC) | not yet recruiting | — | 3,100 | Universidad Miguel Hernandez de ElcheOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT07444983 | Rezvilutamide for High-Risk Prostate Cancer After Surgery | not yet recruiting | N/A | 33 | Fujian Medical University Union HospitalOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT07440641 | RE-FIT (Remote Exercise for Physical Function in WTC Responders With Prostate Cancer)(RE-FIT) | not yet recruiting | N/A | 40 | University of VermontOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT07423117 | A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy | not yet recruiting | Phase 1 | 102 | IntoCell, IncINDUSTRY | 0 | Feb 20, 2026 | clinicaltrials |
| NCT07332832 | Sequential bpMRI for Suspicious Prostate Lesions(SEQ-bpMRI) | not yet recruiting | — | 1,000 | Peking University First HospitalOTHER | 0 | Feb 18, 2026 | clinicaltrials |
| NCT07415135 | Safety and Efficacy of PSMA-Targeted Fluorescent Contrast Agent DGPR1008 for Intraoperative Imaging in Robot-Assisted Radical Prostatectomy | not yet recruiting | Phase 2 | 18 | Zhu YinjieOTHER | 0 | Feb 17, 2026 | clinicaltrials |
| NCT07407686 | Improving Engagement From Underserved Communities With Prostate Cancer Genetics Services(INCLUDE PC) | not yet recruiting | — | 100 | Royal Marsden NHS Foundation TrustOTHER | 0 | Feb 12, 2026 | clinicaltrials |
| NCT07386171 | Micro-Ultrasound for Detecting Clinically Significant Prostate Cancer in Active Surveillance(MUS-AS) | not yet recruiting | N/A | 90 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT07386496 | The Role of 18F-PSMA PET in Prostate Cancer Diagnosis in Equivocal MRI | not yet recruiting | N/A | 250 | Chinese University of Hong KongOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT07381582 | Safety, Tolerability and Preliminary Efficacy of 161Tb-LNC1011 (PSMA Radioligand) in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)(161Tb-LNC1011) | not yet recruiting | Early Phase 1 | 15 | Peking Union Medical College HospitalOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT07376057 | Development and Prospective Validation of a Pathology-Based Artificial Intelligence Model for Predicting the Time to Castration Resistance of Prostate Cancer | not yet recruiting | — | 150 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT07365397 | Imaging Characteristics of Different ⁶⁸Ga-PSMA Probes in Prostate Cancer | not yet recruiting | N/A | 9 | Shanghai Zhongshan HospitalOTHER | 0 | Jan 26, 2026 | clinicaltrials |
| NCT06811454 | Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET) | not yet recruiting | N/A | 76 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT07355504 | Prostate Cancer Early Detection Using Serial MRI Examinations(PROCEDE) | not yet recruiting | N/A | 380 | University Hospital, GrenobleOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT07112612 | Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer | not yet recruiting | — | 50 | Anhui Medical UniversityOTHER | 0 | Jan 12, 2026 | clinicaltrials |
| NCT06660862 | Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer. | not yet recruiting | Phase 4 | 80 | University of ChicagoOTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT07311915 | Propranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treatment in High-Risk Prostate Cancer Patients: A Multicenter, Single-Arm Clinical Study | not yet recruiting | N/A | 30 | Zhongda HospitalOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT07310355 | 68Ga-PSMA-0057 and 177Lu-PSMA-0057 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer | not yet recruiting | Phase 1 / Phase 2 | 49 | Chengdu StarRay Therapeutics Co., LtdINDUSTRY | 0 | Dec 30, 2025 | clinicaltrials |
| NCT07310433 | Dapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metastatic Castrate-resistant Prostate Cancer | not yet recruiting | Phase 2 | 60 | Yung NAOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT07300566 | Focal Versus Whole Gland High Dose-Rate Brachytherapy (HDR-BT) Boost to External Beam Radiotherapy in Localized Prostate Cancer: A Phase 2 Randomized Trial(FORWARD) | not yet recruiting | Phase 2 | 58 | Joelle HelouOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT07280897 | SCIPI Implementation and Evaluation: A Multi-site Proof-of-Concept Pilot Trial(SCIPI) | not yet recruiting | N/A | 200 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Dec 19, 2025 | clinicaltrials |
Data updated 23 days agoSource updated May 18, 2026source: clinicaltrials